Moderna's new Covid-19 vaccine analysis 'giving weight' to annual boosting interval, company says - Endpoints News
endpts.comSubmitted by endpointsnews6292 in health
Moderna’s Covid-19 vaccine study suggests a longer interval between boosters is more beneficial in the general adult population, supporting the FDA’s previous proposal for an annual boosting strategy. Moderna analyzed the efficacy of a single booster of its o…